| 26.2.66
|
CVA Reading 1, p.37, pl.23, no.8; Lemos 1991 p.306, no.1225, pl.159; Villing et al 2013-2015 (ORC) GD.2025 phase 2;
|
|
| 26.2.68
|
CVA Reading 1, p.38, pl.23, no.10a-b; Lemos 1991 p.306, no. 1226, pl.159; Villing et al 2013-2015 (ORC) GD.1213 phase 2;
|
|
| 26.2.70
|
CVA Reading 1, p.38, pl. 23, no.12a-b; Lemos 1991 p.306, no.1227, pl.159; Villing et al 2013-2015 (ORC) GD.2024 phase 2;
|
|
| 26.2.71
|
CVA Reading 1, p.38, pl. 23, no.13a-b; Lemos 1991 p.306, no.1228, pl.159; Villing et al 2013-2015 (ORC) GD.2026 phase 2;
|
|